GlaxoSmithKline Pharmaceuticals opened lower at ₹2,525.10, compared with its previous close of ₹2,531.50. During today's session, the stock has traded between ₹2,495.00 and ₹2,545.00, with an average traded price of ₹2,522.14. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in GlaxoSmithKline Pharmaceuticals is now worth
₹ 17,082.00
giving a profit of
₹ 7,082.00 (70.82%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+4.80 (+0.19%)
Day High
₹2,545.00
Day Low
₹2,495.00
Day Open
₹2,525.10
Prev Close
₹2,531.50
Volume
31,087
Value Traded
₹7.84 Cr
1W Return
-7.19%
1M Return
-10.33%
3M Return
4.02%
6M Return
5.94%
1Y Return
-8.35%
Market Cap (₹ Cr.)
42,966
PE Ratio
40.20
PB Ratio
18.91
Dividend Yield
2.25%
ROE
45.69%
ROCE
55.36%
Book Value (₹)
133.85
Face Value (₹)
10.00
EPS (TTM)
14.00
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-7.19%
6 Week
-
1 Month
-10.33%
3 Month
4.02%
9 Month
5.81%
GSK Pharma closes trading window from Oct 1 ahead of Q2FY27 results
Trading window closed from October 1, 2026. Window reopens 48 hours after Q2FY27 results. Closure complies with SEBI insider trading rules. Board meeting date for results to be announced later.
18 days agoGSK Pharma shareholders approve Karine Natland appointment as non-executive director
Shareholders approved appointment of Karine Natland as non-executive director with 99.71% vote share. Bhushan Akshikar re-appointed as managing director with 99.71% shareholder approval. Promoter group cast all 127 million shares in favor of both resolutions. Total voter turnout stood at approximately 84.7% of eligible shares.
28 days agoGSK India seeks shareholder approval for MD re-appointment, new director
GlaxoSmithKline Pharmaceuticals Ltd seeks shareholder approval for Bhushan Akshikar's re-appointment as MD for two years starting December 2026, with a basic salary up to ₹2.4 crore/month. The ballot also appoints Karine Natland as Non-Executive Director. E-voting runs from August 14 to September 13, 2026.
2mo agoGSK India PAT rises 24% to ₹253.33 crore in Q1FY27 on strong sales
GSK India delivered robust Q1FY27 results with PAT surging 24% to ₹253.33 crore and revenue rising 15% to ₹924.42 crore. The growth was supported by strong brand performance in General Medicines and significant traction in innovative assets like Shingrix and oncology therapies. The company also announced key board appointments and reaffirmed its strategic focus on portfolio transformation.
2mo agoGSK receives ₹52 Cr tax refund for AY 1984-85, books ₹42 Cr interest income
GlaxoSmithKline Pharmaceuticals Limited secured a ₹52.00 crore tax refund for Assessment Year 1984-85 on August 6, 2026. Following the Order Giving Effect dated January 27, 2026, the company also recognized ₹42.09 crore in interest income. This resolution concludes a long-standing tax matter, providing a non-operational boost to the company's profitability.
2mo agoGSK Pharma uploads analyst meeting recordings per SEBI rules
GSK Pharma uploaded recordings of analyst meetings on August 5, 2026, complying with SEBI LODR regulations to ensure market transparency and prevent information asymmetry.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in GlaxoSmithKline Pharmaceuticals is now worth
₹ 17,082.00
giving a profit of
₹ 7,082.00 (70.82%)
Note: Past profits do not guarantee future returns.
